Letter: Cardiovascular risk of tenofovir disoproxil fumarate or tenofovir alafenamide fumarate in patients with chronic hepatitis B: More questions than an answer - author's reply

被引：1
|
作者：
Hong, Hyeyeon [1 ]
Choi, Jonggi [1 ]
机构：
[1] Univ Ulsan, Liver Ctr, Asan Med Ctr, Dept Gastroenterol,Coll Med, Seoul, South Korea
来源：
CLINICAL AND MOLECULAR HEPATOLOGY | 2024年 / 30卷 / 02期
基金：
新加坡国家研究基金会;
关键词：
Antiviral agent; Tenofovir; Lipid; DOUBLE-BLIND; PHASE-3;
D O I：
10.3350/cmh.2024.0123
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Cardiovascular risk of tenofovir disoproxil fumarate or tenofovir alafenamide in patients with chronic hepatitis B: More questions than an answer
    Cheng, Pin -Nan
    Yu, Ming -Lung
    CLINICAL AND MOLECULAR HEPATOLOGY, 2024, 30 (02)
  • [2] Reply to correspondence on "Cardiovascular risk in chronic hepatitis B patients treated with tenofovir disoproxil fumarate or tenofovir alafenamide"
    Cheng, Pin-Nan
    Yu, Ming-Lung
    CLINICAL AND MOLECULAR HEPATOLOGY, 2024, 30 (04)
  • [3] Cardiovascular risk in chronic hepatitis B patients treated with tenofovir disoproxil fumarate or tenofovir alafenamide
    Hong, Hyeyeon
    Choi, Won-Mook
    Lee, Danbi
    Shim, Ju Hyun
    Kim, Kang Mo
    Lim, Young-Suk
    Lee, Han Chu
    Choi, Jonggi
    CLINICAL AND MOLECULAR HEPATOLOGY, 2024, 30 (01) : 49 - 63
  • [4] Comparable risk of cardiovascular events in chronic hepatitis B patients treated with tenofovir disoproxil fumarate or tenofovir alafenamide
    Hong, Hyeyeon
    Choi, Jonggi
    Choi, Won-Mook
    Lee, Danbi
    Shim, Ju Hyun
    Kim, Kang Mo
    Lim, Young-Suk
    Lee, Han Chu
    JOURNAL OF HEPATOLOGY, 2023, 78 : S1139 - S1139
  • [5] COMPARATIVE SAFETY OF TENOFOVIR DISOPROXIL FUMARATE AND TENOFOVIR ALAFENAMIDE IN CHRONIC HEPATITIS B PATIENTS
    Yu, N. Y.
    Chang, K. C.
    VALUE IN HEALTH, 2020, 23 : S532 - S532
  • [6] EFFECTS OF TENOFOVIR ALAFENAMIDE FUMARATE VERSUS TENOFOVIR DISOPROXIL FUMARATE ON SERUM LIPID PROFILES IN PATIENTS WITH CHRONIC HEPATITIS B
    Cao, Fei
    Fan, Tao
    Jiang, Xue
    Wang, Jian
    Xiong, Ye
    Zhang, Shaoqiu
    Zhang, Zhiyi
    Liu, Xingxiang
    Zhu, Chuanwu
    Li, Jie
    Huang, Rui
    Wu, Chao
    HEPATOLOGY, 2024, 80 : S298 - S298
  • [7] Tenofovir alafenamide and tenofovir disoproxil fumarate reduce incidence of hepatocellular carcinoma in patients with chronic hepatitis B
    Lim, Young-Suk
    Chan, Henry L. Y.
    Ahn, Sang Hoon
    Seto, Wai Kay
    Ning, Qin
    Agarwal, Kosh
    Janssen, Harry L. A.
    Pan, Calvin Q.
    Chuang, Wan Long
    Izumi, Namiki
    Fung, Scott
    Shalimar, Maurizia
    Brunetto, Maurizia
    Hui, Aric Josun
    Chang, Ting-Tsung
    Lim, Seng Gee
    Abramov, Frida
    Flaherty, John F.
    Wang, Hongyuan
    Yee, Leland J.
    Kao, Jia-Horng
    Gane, Edward
    Hou, Jinlin
    Buti, Maria
    JHEP REPORTS, 2023, 5 (10)
  • [8] Atherosclerotic cardiovascular disease risk profile of patients with chronic hepatitis B treated with tenofovir alafenamide or tenofovir disoproxil fumarate for 96 weeks
    Fung, Scott K.
    Pan, Calvin Q.
    Wong, Grace Lai-Hung
    Seto, Wai-Kay
    Ahn, Sang Hoon
    Chen, Chi-Yi
    Hann, Hie-Won L.
    Jablkowski, Maciej S.
    Kim, Yoon Jun
    Yurdaydin, Cihan
    Peng, Cheng-Yuan
    Nguyen, Tuan
    Yatsuhashi, Hiroshi
    Flaherty, John F.
    Yee, Leland J.
    Abramov, Frida
    Wang, Hongyuan
    Abdurakhmanov, Dzhamal
    Lim, Young-Suk
    Buti, Maria
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 59 (02) : 217 - 229
  • [9] Therapeutic effectiveness analysis of tenofovir alafenamide and tenofovir disoproxil fumarate on the treatment for chronic hepatitis B
    Liu, Rui
    Qiao, Jin
    Zhang, Lin
    Dou, Zhihua
    MEDICINE, 2024, 103 (20) : E37953
  • [10] Effect of tenofovir alafenamide vs. tenofovir disoproxil fumarate on hepatocellular carcinoma risk in chronic hepatitis B
    Lee, Hye Won
    Cho, Young Youn
    Lee, Hyein
    Lee, Jae Seung
    Kim, Seung Up
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Kim, Beom Kyung
    Park, Soo Young
    JOURNAL OF VIRAL HEPATITIS, 2021, 28 (11) : 1570 - 1578
12345